Should patients stop their biologic treatment during the COVID-19 pandemic

Arjun M Bashyam¹, Steven R Feldman^{1

2

3

4}

Affiliations

¹ Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
² Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
³ Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina.
⁴ Department of Dermatology, University of Southern Denmark, Odense, Denmark.

Free article

Editorial

Arjun M Bashyam et al. J Dermatolog Treat. 2020 Jun.

Free article

. 2020 Jun;31(4):317-318.

doi: 10.1080/09546634.2020.1742438. Epub 2020 Mar 19.

Arjun M Bashyam¹, Steven R Feldman^{1

2

3

4}

¹ Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
² Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
³ Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina.
⁴ Department of Dermatology, University of Southern Denmark, Odense, Denmark.

No abstract available

Comment in

Biological treatment during COVID-19 outbreak.
Sriwijitalai W, Wiwanitkit V. Sriwijitalai W, et al. J Dermatolog Treat. 2020 Jun;31(4):324. doi: 10.1080/09546634.2020.1749548. Epub 2020 Apr 13. J Dermatolog Treat. 2020. PMID: 32223353 No abstract available.